Qps Bioserve India Profile
Key Indicators
- Authorised Capital ₹ 4.25 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.88 Cr
as on 16-11-2024
- Company Age 20 Year, 16 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.42 M
as on 16-11-2024
- Satisfied Charges ₹ 16.53 Cr
as on 16-11-2024
- Revenue -33.19%
(FY 2023)
- Profit -58.50%
(FY 2023)
- Ebitda -57.59%
(FY 2023)
- Net Worth -46.49%
(FY 2023)
- Total Assets -42.71%
(FY 2023)
About Qps Bioserve India
The Corporate was formerly known as Bioserve Clinical Research Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.25 Cr and a paid-up capital of Rs 3.88 Cr.
The company currently has active open charges totaling ₹1.42 M. The company has closed loans amounting to ₹16.53 Cr, as per Ministry of Corporate Affairs (MCA) records.
Benjamin Chien, Kumar Ramu, and Chang Yen serve as directors at the Company.
- CIN/LLPIN
U85110TG2004PTC044908
- Company No.
044908
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
What products or services does Qps Bioserve India Private Limited offer?
Qps Bioserve India Private Limited offers a wide range of products and services, including Pharmaceutical Services, Pharmaceutical Testing Services, Pharma & Bioanalytical Services, Bioanalytical Services, Medical Consultants & Clinics, Medical Consultancy Services.
Who are the key members and board of directors at Qps Bioserve India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Benjamin Chien  | Nominee Director | 11-Mar-2011 | Current |
| Kumar Ramu | Nominee Director | 11-Mar-2011 | Current |
Chang Yen  | Nominee Director | 11-Mar-2011 | Current |
Financial Performance of Qps Bioserve India.
Qps Bioserve India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.19% decrease. The company also saw a substantial fall in profitability, with a 58.5% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Qps Bioserve India?
In 2023, Qps Bioserve India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 31 Mar 2005 | ₹1.42 M | Open |
Ge Capital Services India Creation Date: 20 Jan 2011 | ₹9.21 M | Satisfied |
Ge Capital Services India Creation Date: 08 Dec 2010 | ₹1.96 Cr | Satisfied |
How Many Employees Work at Qps Bioserve India?
Qps Bioserve India has a workforce of 167 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Qps Bioserve India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qps Bioserve India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
